PHARMACEUTICAL COMPOSITION CONTAINING STEM CELL-CONDITIONED MEDIUM POWDER FOR PREVENTING, TREATING, OR ALLEVIATING DISEASES RELATED TO CRANIAL NERVES OR SPINAL NERVES
PURPOSE: A pharmaceutical composition for preventing, treating, or alleviating diseases related to cranial nerves or spinal nerves is provided to treat cerebral infarction using stem cell-conditioned medium powder.CONSTITUTION: A pharmaceutical composition for preventing, treating, or alleviating diseases related to cranial nerves or spinal nerves contains conditioned medium powder. The conditioned medium powder is prepared by culturing stem cells in a serum-free medium and freeze-drying the medium. The diseases related to cranial nerves or spinal nerves includes cerebral infarction, stroke, cerebral inflammatory disease, brain injury, traumatic brain injury, Alzheimers disease, Parkinsons disease, depression, epilepsy, multiple sclerosis, or mania. The serum-free medium contains growth factors or cytokines.COPYRIGHT KIPO 2013[Reference numerals] (AA) In vivo experiment design (BB) In vitro experiment design
